Search - tctmd.com

Displaying 861 - 880 of 1160

Sort: Relevancy | Date

News Daily News

La Terapia Antiplaquetaria Triple podría ser Mejor para Longitudes de Stent Más Largas

Jason Kahn

September 27, 2013

News Daily News

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Yael L. Maxwell

September 20, 2013

News Daily News

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

Yael L. Maxwell

September 20, 2013

News Conference News ESC 2013

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Yael L. Maxwell

September 01, 2013

News Daily News

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

August 30, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

Oral Sirolimus Appears to Augment Efficacy of BMS

Caitlin E. Cox

August 23, 2013

News Daily News

Meta-analysis: DES More Effective Than BMS for STEMI with No Safety Trade-off

L.A. McKeown

August 19, 2013

News Daily News

Contemporary ZES Perform Well in Treating In-Stent Restenosis

August 14, 2013

News Daily News

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

L.A. McKeown

August 12, 2013

News Daily News

Performance of Bioabsorbable Scaffold Can Be Tracked with Noninvasive CT

August 08, 2013

News Daily News

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

August 08, 2013

News Industry News

First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich’s COMBO Dual Therapy Stent™ in Routine Practice

August 06, 2013

News Daily News

Staged Stenting Best for Patients with Carotid Disease Prior to Heart Surgery

Caitlin E. Cox

August 05, 2013

News Daily News

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

July 25, 2013

News Daily News

For A-fib Patients, Aspirin on Top of Anticoagulation Raises Bleeding Risk

Caitlin E. Cox

July 25, 2013

News Daily News

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

July 25, 2013

News Daily News

Novel Mechanism for Potential Cardiovascular Harm from PPIs Identified

July 24, 2013

News Daily News

Después de un accidente cerebrovascular menor/AIT, la terapia antiplaquetaria doble reduce el accidente cerebrovascular recurrente en comparación con la aspirina

July 24, 2013

News Daily News

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

July 24, 2013

Advertisement

La Terapia Antiplaquetaria Triple podría ser Mejor para Longitudes de Stent Más Largas

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Oral Sirolimus Appears to Augment Efficacy of BMS

Meta-analysis: DES More Effective Than BMS for STEMI with No Safety Trade-off

Contemporary ZES Perform Well in Treating In-Stent Restenosis

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

Performance of Bioabsorbable Scaffold Can Be Tracked with Noninvasive CT

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich’s COMBO Dual Therapy Stent™ in Routine Practice

Staged Stenting Best for Patients with Carotid Disease Prior to Heart Surgery

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

For A-fib Patients, Aspirin on Top of Anticoagulation Raises Bleeding Risk

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

Novel Mechanism for Potential Cardiovascular Harm from PPIs Identified

Después de un accidente cerebrovascular menor/AIT, la terapia antiplaquetaria doble reduce el accidente cerebrovascular recurrente en comparación con la aspirina

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content